NCT05379192

Brief Summary

These circadian rhythms are self-sustained, endogenous oscillations generated by circadian clocks that persist with a period of around 24 -h under constant conditions. Multiple clinical and foundational science studies report that circadian rhythm disruption can directly alter pain thresholds. Altered circadian pain rhythms manifest inconsistently in various disease states. circadian differences exist in tolerability of administration as well as in effectiveness of analgesia during surgical, obstetric, and dental procedures, with the majority of studies demonstrating highest pain sensitivity during the overnight or early morning hours. Although the relationship between pain states and circadian rhythm has been studied in various surgical procedures and chronic pain syndromes, there is little literature examining the relationship between postoperative pain and circadian rhythm in pediatric surgical procedures. Therefore, it was aimed to evaluate the relationship between postoperative pain and circadian rhythm after pediatric acute appendicitis surgery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2022

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2022

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

April 29, 2022

Completed
19 days until next milestone

First Posted

Study publicly available on registry

May 18, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 15, 2022

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

May 18, 2022

Status Verified

May 1, 2022

Enrollment Period

8 months

First QC Date

April 29, 2022

Last Update Submit

May 17, 2022

Conditions

Outcome Measures

Primary Outcomes (10)

  • The postoperative VAS pain scores

    The VAS scores at 1st will be recorded.

    1st hours , postoperatively

  • The postoperative VAS pain scores

    The VAS scores at 2nd will be recorded.

    2nd hours , postoperatively

  • The postoperative VAS pain scores

    The VAS scores at 3th will be recorded.

    3th hours , postoperatively

  • The postoperative VAS pain scores

    The VAS scores at 6th will be recorded.

    6th hours , postoperatively

  • The postoperative VAS pain scores

    The VAS scores at 9th will be recorded.

    9th hours , postoperatively

  • The postoperative VAS pain scores

    The VAS scores at 12th will be recorded.

    12th hours , postoperatively

  • The postoperative VAS pain scores

    The VAS scores at 15th will be recorded.

    15th hours , postoperatively

  • The postoperative VAS pain scores

    The VAS scores at 18th will be recorded.

    18th hours , postoperatively

  • The postoperative VAS pain scores

    The VAS scores at 21th will be recorded.

    21th hours , postoperatively

  • The postoperative VAS pain scores

    The VAS scores at 24th will be recorded.

    24th hours , postoperatively

Secondary Outcomes (2)

  • The total amount of analgesic

    24 hours, postoperatively

  • the time to first analgesia requirement

    24 hours, postoperatively

Study Arms (4)

Group 1

Sociodemographic and clinical data of the patients who will be operated between 01:01-07:00 AM will be recorded. The total amount of antiemetic, the time of first antiemetic use, and the VAS scores at the postoperative 1, 2, 3, 6, 9, 12, 15, 18, 21 and 24th hours will also be recorded.

Other: Group 1, Group 2, Group 3, Group 4

Group 2

Patients who were operated between 07:01-13:00. Sociodemographic and clinical data of the patients who will be operated between 07:00 AM- 01:00 PM will be recorded. The total amount of antiemetic, the time of first antiemetic use, and the VAS scores at the postoperative 1, 2, 3, 6, 9, 12, 15, 18, 21 and 24th hours will also be recorded.

Other: Group 1, Group 2, Group 3, Group 4

Group 3

Sociodemographic and clinical data of the patients who will be operated between 01:00 - 08:00 PM will be recorded. The total amount of antiemetic, the time of first antiemetic use and the VAS scores at the postoperative 1, 2, 3, 6, 9, 12, 15, 18, 21 and 24th hours will also be recorded.

Other: Group 1, Group 2, Group 3, Group 4

Group 4

Sociodemographic and clinical data of the patients who will be operated between 08:00 PM -01:00 AM will be recorded. The total amount of antiemetic,the time of first antiemetic use, and the VAS scores at the postoperative 1, 2, 3, 6, 9, 12, 15, 18, 21 and 24th hours will also be recorded.

Other: Group 1, Group 2, Group 3, Group 4

Interventions

The total amount of antiemetic,the time of first antiemetic use and VAS scores at 1, 2, 3, 6, 9, 12, 15, 18, 21 and 24th hours postoperatively will also be recorded according to circadian rhythm

Group 1Group 2Group 3Group 4

Eligibility Criteria

Age6 Years - 18 Years
Sexall(Gender-based eligibility)
Gender Eligibility DetailsPostoperative pain differs in both sexes according to the circadian rhythm.
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

Pediatric patient population of both sexes aged 6-18 years

You may qualify if:

  • American Society of Anesthesiologists (ASA) physical condition I-II,
  • Undergoing acute appendicitis,
  • Patients aged 6-18 years

You may not qualify if:

  • ASA ≥ III,
  • Uncontrolled chronic, metabolic disease,
  • Opioid or analgesic use in the last 10 days,
  • Acute peritonitis or sepsis
  • History of abnormal operation or recovery from anesthesia,
  • Patients with parents who are unwilling to give informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Selcuk University, School of Medicine

Konya, 42080, Turkey (Türkiye)

Location

Selcuk University, School of Medicine

Konya, 42250, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate Prof.

Study Record Dates

First Submitted

April 29, 2022

First Posted

May 18, 2022

Study Start

January 1, 2022

Primary Completion

August 15, 2022

Study Completion

December 31, 2022

Last Updated

May 18, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share

I do not have a plan to make individual participant data (IPD) available to other researchers.

Locations